1-26951532-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_152365.3(KDF1):c.849G>A(p.Thr283Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0342 in 1,612,838 control chromosomes in the GnomAD database, including 1,128 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.025 ( 62 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1066 hom. )
Consequence
KDF1
NM_152365.3 synonymous
NM_152365.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.55
Genes affected
KDF1 (HGNC:26624): (keratinocyte differentiation factor 1) Predicted to be involved in several processes, including positive regulation of epidermal cell differentiation; regulation of epidermal cell division; and skin development. Predicted to act upstream of or within keratinocyte development and negative regulation of keratinocyte proliferation. Located in cell junction; mitotic spindle; and nucleoplasm. Implicated in ectodermal dysplasia 12. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 1-26951532-C-T is Benign according to our data. Variant chr1-26951532-C-T is described in ClinVar as [Benign]. Clinvar id is 1594784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.55 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0246 (3748/152300) while in subpopulation NFE AF= 0.039 (2653/68016). AF 95% confidence interval is 0.0378. There are 62 homozygotes in gnomad4. There are 1793 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3748 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDF1 | NM_152365.3 | c.849G>A | p.Thr283Thr | synonymous_variant | 2/4 | ENST00000320567.6 | NP_689578.2 | |
KDF1 | XM_005245735.3 | c.849G>A | p.Thr283Thr | synonymous_variant | 2/4 | XP_005245792.1 | ||
KDF1 | XM_011540622.3 | c.849G>A | p.Thr283Thr | synonymous_variant | 2/4 | XP_011538924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDF1 | ENST00000320567.6 | c.849G>A | p.Thr283Thr | synonymous_variant | 2/4 | 2 | NM_152365.3 | ENSP00000319179.5 |
Frequencies
GnomAD3 genomes AF: 0.0246 AC: 3748AN: 152182Hom.: 62 Cov.: 32
GnomAD3 genomes
AF:
AC:
3748
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0242 AC: 6072AN: 251172Hom.: 106 AF XY: 0.0242 AC XY: 3281AN XY: 135808
GnomAD3 exomes
AF:
AC:
6072
AN:
251172
Hom.:
AF XY:
AC XY:
3281
AN XY:
135808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0352 AC: 51340AN: 1460538Hom.: 1066 Cov.: 31 AF XY: 0.0341 AC XY: 24754AN XY: 726258
GnomAD4 exome
AF:
AC:
51340
AN:
1460538
Hom.:
Cov.:
31
AF XY:
AC XY:
24754
AN XY:
726258
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0246 AC: 3748AN: 152300Hom.: 62 Cov.: 32 AF XY: 0.0241 AC XY: 1793AN XY: 74454
GnomAD4 genome
AF:
AC:
3748
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
1793
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
KDF1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 14, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at